BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 32799573)

  • 1. In our war against the opioid epidemic, could 'weed' be a winner?
    Ding DD; Balkrishnan R; Diaby V
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):423-429. PubMed ID: 32799573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.
    Shi Y; Liang D; Bao Y; An R; Wallace MS; Grant I
    Drug Alcohol Depend; 2019 Jan; 194():13-19. PubMed ID: 30390550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
    Bachhuber MA; Saloner B; Cunningham CO; Barry CL
    JAMA Intern Med; 2014 Oct; 174(10):1668-73. PubMed ID: 25154332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
    Nguyen HV; McGinty EE; Mital S; Alexander GC
    JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic.
    Bleyer A; Barnes B; Finn K
    J Opioid Manag; 2024; 20(2):119-132. PubMed ID: 38700393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.
    Beauchamp GA; Winstanley EL; Ryan SA; Lyons MS
    Am J Public Health; 2014 Nov; 104(11):2023-9. PubMed ID: 25211712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
    DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
    Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.
    Park JN; Rouhani S; Beletsky L; Vincent L; Saloner B; Sherman SG
    Milbank Q; 2020 Sep; 98(3):700-746. PubMed ID: 32808709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing Individuals.
    Hammond AS; Dunn KE; Strain EC
    J Addict Med; 2020; 14(1):56-62. PubMed ID: 31385846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What would it really take to solve the overdose epidemic in the United States?
    Rivera BD; Friedman SR
    Int J Drug Policy; 2024 Jun; 128():104435. PubMed ID: 38729061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do medical marijuana laws reduce addictions and deaths related to pain killers?
    Powell D; Pacula RL; Jacobson M
    J Health Econ; 2018 Mar; 58():29-42. PubMed ID: 29408153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the impact of simulated educational interventions on the use and abuse of pharmaceutical opioids in the United States: a report on initial efforts.
    Wakeland W; Nielsen A; Schmidt TD; McCarty D; Webster LR; Fitzgerald J; Haddox JD
    Health Educ Behav; 2013 Oct; 40(1 Suppl):74S-86S. PubMed ID: 24084403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.
    Shi Y
    Drug Alcohol Depend; 2017 Apr; 173():144-150. PubMed ID: 28259087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Are Telehealth Laws Intersecting With Laws Addressing the Opioid Overdose Epidemic?
    Pepin D; Hulkower R; McCord RF
    J Public Health Manag Pract; 2020; 26(3):227-231. PubMed ID: 31348152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Federal Response to the Opioid Crisis.
    Johnson K; Jones C; Compton W; Baldwin G; Fan J; Mermin J; Bennett J
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):293-301. PubMed ID: 29968173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Opioid Industry Documents Archive: Advancing Public Health Through Industry Document Disclosure.
    Caleb Alexander G; Tasker K
    J Law Med Ethics; 2024; 52(1):133-135. PubMed ID: 38818587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing Bioethical Implications of Implementing Diversion Programs in Resource-Constrained Service Environments.
    Korchmaros JD; Hall K
    J Law Med Ethics; 2024; 52(1):76-79. PubMed ID: 38818588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis.
    Sarvet AL; Wall MM; Fink DS; Greene E; Le A; Boustead AE; Pacula RL; Keyes KM; Cerdá M; Galea S; Hasin DS
    Addiction; 2018 Jun; 113(6):1003-1016. PubMed ID: 29468763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marijuana Use in the Era of Changing Cannabis Laws: What Are the Risks? Who is Most at Risk?
    Stoecker WV; Rapp EE; Malters JM
    Mo Med; 2018; 115(5):398-404. PubMed ID: 30385981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada.
    Michaud L; Kolla G; Rudzinski K; Guta A
    Int J Drug Policy; 2024 May; 127():104423. PubMed ID: 38642543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.